Printer Friendly
The Free Library
14,610,698 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Taisho Pharmaceutical Purchases Additional Shares of Yomeishu Seizo.


Tokyo, Japan, Apr 20, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Taisho Pharmaceutical Taisho Pharmaceutical Co., Ltd. (大正製薬株式会社   has increased its stake in Yomeishu Seizo, a Japanese company famous for the herbal herbal, early botanical book containing descriptions and illustrations of herbs and plants with their properties, chiefly those qualities that made them useful as medicines or condiments. Most of the herbals were written between c.1470 and c.  health drink Yomeishu.

Taisho purchased 1,805,000 shares of Yomeishu Seizo's common stock in off-hours trading at the Tokyo Stock Exchange Tokyo Stock Exchange

Main stock market of Japan, located in Tokyo. It opened in 1878 to provide a market for the trading of government bonds newly issued to former samurai.
 on April 18, increasing its stake in the company from 14.5% to 20.0%.

With this move, Taisho aims to strengthen its partnership with Yomeishu Seizo and expand each company's business.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Apr 20, 2006
Words:86
Previous Article:Yokohama Rubber to Produce Steel Radial Tires for Trucks and Buses in China.
Next Article:Japan Tobacco, GlaxoSmithKline Conclude Licensing Agreement for New Drug Candidate.



Related Articles
QUARK SIGNS RESEARCH PACT WITH SHIONOGI.
Taisho Pharmaceutical Opens Two New Health Information Websites for Mobile Phones.
Sanofi-aventis Japan Acquires Production and Sales Rights of Ancaron Antiarrhythmic Agent from Taisho Pharmaceutical.
Astellas Pharma, Taisho Pharmaceutical Both Deny Acquisition of Zepharma by Taisho Pharmaceutical.
Astellas and Toyama Chemical Announce Basic Licensing Agreement on Domestic Marketing and Joint Development of Quinolone Antibiotic T-3811.
Taisho Pharmaceutical, Yayoi Foods to Join Hands in Food Business.
Morristown's Mt. Kemble Corporate Center sold.(NEW JERSEY)
Chugai Announces Co-Development and Co-Marketing Agreement with Taisho Pharmaceutical for the Antiresorptive Bisphosphonate R484.
Chugai and Taisho to Co-Develop and Market Antiresorptive Bisphosphonate R484.
Eisai Lawsuit Against Generic Drug Manufacturers Dismissed.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles